Severity of enterocolitis is predicted by IL-8 in paediatric oncology patients

European Journal of Cancer

Volumn 40, Issue 4, 2004, Pages 571-578

  Van De Wetering, M D ^a   Caron, H N ^a   Biezeveld, M ^a   Taminiau, J A J M ^a   Ten Kate, F J ^b   Spanjaard, L ^b   Kuijpers, T W ^a  

^a EMMA CHILDREN S HOSPITAL   (Netherlands)

^b Department of Pathology ^*  (Netherlands)

Author keywords

Cl. difficile; IL 8; Neutropenic enterocolitis; Prognostic markers

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 8;

ABDOMINAL PAIN; ARTICLE; BACTERIUM CULTURE; BIOLOGICAL MONITORING; CANCER MORTALITY; CANCER PATIENT; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; CLINICAL FEATURE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIARRHEA; DISEASE MARKER; DISEASE SEVERITY; ENTEROCOLITIS; FEBRILE NEUTROPENIA; FEMALE; GRAM POSITIVE BACTERIUM; HIGH RISK PATIENT; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; INTENSIVE CARE UNIT; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; RECTUM BIOPSY; RISK FACTOR; SAMPLE SIZE;

EID: 1242316326     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2003.10.021     Document Type: Article

References (31)

1. Gandy W., Greenberg B.R. Successful medical management of neutropenic enterocolitis. Cancer. 51:1983;1551-1555.
2. Gartell P., Braye S.G., Copplestone J.A. Neutropenic typhlitis. Dis Colon Rectum. 27:1984;274-275.
3. Gomez L., Martino R., Rolston K.V. Neutropenic enterocolitis. spectrum of the disease and comparison of definite and possible cases Clin Infect Dis. 27:1998;695-699.
4. Shamberger R.C., Weinstein H.J., Delorey M.J., Levey R.H. The medical and surgical management of typhlitis in children with acute nonlymphocytic (myelogenous) leukaemia. Cancer. 57:1986;603-609.
5. Cooke X. Submucosal hemorrhage and appendiceal perforation in children with leukaemia. JAMA. 101:1933;432-435.
6. Lev R., Sweeney K.G. Neutropenic enterocolitis. Two unusual cases with review of the literature. Arch Pathol Lab Med. 117:1993;524-527.
7. Wade D.S., Nava H.R., Douglass H.O. Jr. Neutropenic enterocolitis. Clinical diagnosis and treatment. Cancer. 69:1992;17-23.
8. Blijlevens N.M., Donnelly J.P., De Pauw B.E. Mucosal barrier injury. biology, pathology, clinical counterparts and consequences of intensive treatment for haematological malignancy: an overview Bone Marrow Transplant. 25:2000;1269-1278.
9. Engervall P., Andersson B., Bjorkholm M. Clinical significance of serum cytokine patterns during start of fever in patients with neutropenia. Br J Haematol. 91:1995;838-845.
10. de Bont E.S., Vellenga E., Swaanenburg J.C.et al. Plasma IL-8 and IL-6 levels can be used to define a group with low risk of septicaemia among cancer patients with fever and neutropenia. Br J Haematol. 107:1999;375-380.
11. Engel A., Mack E., Kern P., Kern W.V. An analysis of interleukin-8, interleukin-6 and C-reactive protein serum concentrations to predict fever, gram-negative bacteremia and complicated infection in neutropenic cancer patients. Infection. 26:1998;213-221.
12. Kern W.V., Heiss M., Steinbach G. Prediction of gram-negative bacteremia in patients with cancer and febrile neutropenia by means of interleukin-8 levels in serum. targeting empirical monotherapy versus combination therapy Clin Infect Dis. 32:2001;832-835.
13. Fleischhack G., Kambeck I., Cipic D., Hasan C., Bode U. Procalcitonin in paediatric cancer patients. its diagnostic relevance is superior to that of C-reactive protein, interleukin 6, interleukin 8, soluble interleukin 2 receptor and soluble tumour necrosis factor receptor II Br J Haematol. 111:2000;1093-1102.
14. Berkes J., Viswanathan V.K., Savkovic S.D., Hecht G. Intestinal epithelial responses to enteric pathogens. effects on the tight junction barrier, ion transport, and inflammation Gut. 52:2003;439-451.
15. Karakurum M., Shreeniwas R., Chen J.et al. Hypoxic induction of interleukin-8 gene expression in human endothelial cells. J. Clin. Invest. 93:1994;1564-1570.
16. Wolbink G.J., Brouwer M.C., Buysmann S., ten Berge I.J., Hack C.E. CRP-mediated activation of complement in vivo. assessment by measuring circulating complement-C-reactive protein complexes J. Immunol. 157:1996;473-479.
17. Moir D.H., Turner J.J., Ma D.D., Biggs J.C. Autopsy findings in bone marrow transplantation. Pathology. 14:1982;197-204.
18. Prolla J.C., Kirsner J.B. The gastrointestinal lesions and complications of the leukaemia's. Ann Intern Med. 61:1964;1084-1103.
19. Baerg J., Murphy J.J., Anderson R., Magee J.F. Neutropenic enteropathy. a 10-year review J Pediatr Surg. 34:1999;1068-1071.
20. Anand A., Bashey B., Mir T., Glatt A.E. Epidemiology, clinical manifestations, and outcome of Clostridium difficile-associated diarrhoea. Am J Gastroenterol. 89:1994;519-523.
21. Riley T.V. Clostridium difficile. a pathogen of the nineties Eur J Clin Microbiol Infect Dis. 17:1998;137-141.
22. Wagner M.L., Rosenberg H.S., Fernbach D.J., Singleton E.B. Typhlitis. a complication of leukaemia in childhood Am J Roentgenol Radium Ther Nucl Med. 109:1970;341-350.
23. Katz J.A., Wagner M.L., Gresik M.V., Mahoney D.H. Jr., Fernbach D.J. Typhlitis. An 18-year experience and postmortem review. Cancer. 65:1990;1041-1047.
24. Song H.K., Kreisel D., Canter R.et al. Changing presentation and management of neutropenic enterocolitis. Arch Surg. 133:1998;979-982.
25. Woo P.C., Wong S.S., Lum P.N., Hui W.T., Yuen K.Y. Cell-wall-deficient bacteria and culture-negative febrile episodes in bone-marrow-transplant recipients. Lancet. 357:2001;675-679.
26. Sloas M.M., Flynn P.M., Kaste S.C., Patrick C.C. Typhlitis in children with cancer. a 30-year experience Clin Infect Dis. 17:1993;484-490.
27. Cartoni C., Dragoni F., Micozzi A.et al. Neutropenic enterocolitis in patients with acute leukaemia: prognostic significance of bowel wall thickening detected by ultrasonography. J Clin Oncol. 19:2001;756-761.
28. Gorschluter M., Marklein G., Hofling K.et al. Abdominal infections in patients with acute leukaemia: a prospective study applying ultrasonography and microbiology. Br J Haematol. 117:2002;351-358.
29. van Woensel J.B., Biezeveld M.H., Alders A.M.et al. Adrenocorticotropic hormone and cortisol levels in relation to inflammatory response and disease severity in children with meningococcal disease. J Infect Dis. 184:2001;1532-1537.
30. Colgan S.P., Dzus A.L., Parkos C.A. Epithelial exposure to hypoxia modulates neutrophil transepithelial migration. J. Exp. Med. 184:1996;1003-1015.
31. Tilg H., Dinarello C.A., Mier J.W. IL-6 and APPs. anti-inflammatory and immunosuppressive mediators Immunol. Today. 18:1997;428-432.